Valuation Guiyang Xintian Pharmaceutical Co.,Ltd.

Stocks

End-of-day quote Shenzhen S.E. 2026-11-06			5-day change	1st Jan Change
7.550 ^CNY	-1.82%		+2.44%	-23.89%

10-28	Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
08-25	Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,869	3,224	3,339	2,868	2,190	2,334
Change	-	72.49%	3.58%	-14.13%	-23.62%	6.57%
Enterprise Value (EV) ¹	1,985	3,501	3,725	3,331	2,632	2,829
Change	-	76.35%	6.39%	-10.56%	-20.99%	7.49%
P/E	27x	35.1x	30.4x	37.7x	39.9x	256x
PBR	2.26x	3.7x	2.97x	2.59x	1.87x	1.86x
PEG	-	1x	1.9x	-1.2x	-1.4x	-3.1x
Capitalization / Revenue	2.49x	3.32x	3.07x	3.01x	2.55x	3.11x
EV / Revenue	2.64x	3.61x	3.42x	3.49x	3.07x	3.77x
EV / EBITDA	19x	23.7x	24.1x	29.2x	29.5x	50.8x
EV / EBIT	23x	27.7x	28.4x	35.2x	45.3x	124x
EV / FCF	32x	-384x	-39.6x	-90.2x	-405x	509x
FCF Yield	3.12%	-0.26%	-2.53%	-1.11%	-0.25%	0.2%
Dividend per Share ²	0.0612	0.0857	0.1	0.07	0.1	0.03
Rate of return	0.74%	0.59%	0.69%	0.56%	1.06%	0.3%
EPS ²	0.3071	0.4111	0.4762	0.3307	0.2375	0.0387
Distribution rate	19.9%	20.8%	21%	21.2%	42.1%	77.5%
Net sales ¹	750.9	969.8	1,088	954	857.5	749.7
EBITDA ¹	104.7	147.5	154.7	114	89.14	55.74
EBIT ¹	86.39	126.6	131	94.72	58.11	22.86
Net income ¹	74.1	100.6	116.1	80.87	52.32	9.111
Net Debt ¹	116.3	277.3	385.4	463.7	441.9	495.1
Reference price ²	8.296	14.429	14.480	12.460	9.470	9.920
Nbr of stocks (in thousands)	225,289	223,426	230,611	230,138	231,281	235,298
Announcement Date	4/30/21	3/25/22	3/27/23	4/11/24	4/24/25	3/30/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD.	-	-	-	-	269M
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,206B
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	665B
ABBVIE INC.	37.45x	8.51x	17.57x	2.38%	515B
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	381B
MERCK & CO., INC.	97.18x	5.95x	25.33x	2.32%	362B
NOVARTIS AG	23.18x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	289B
AMGEN INC.	23.66x	7.32x	13.53x	2.19%	249B
GILEAD SCIENCES, INC.	-39.95x	7.29x	45.82x	1.98%	207B
Average	29.67x	7.25x	21.19x	2.04%	418B
Weighted average by Cap.	35.62x	8.55x	21.86x	1.73%